Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells

Cancer Research

Volumn 61, Issue 18, 2001, Pages 6918-6924

  Huang, Ying ^a   He, Qin ^a   Hillman, Michael J ^a   Rong, Rong ^a   Sheikh, M Saeed ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; RECEPTOR; RNA; SULINDAC; SULINDAC SULFIDE; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 8; CASPASE 9; CASPASES; COLONIC NEOPLASMS; ENZYME ACTIVATION; HT29 CELLS; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; SULINDAC; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0035884187     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. The role of cyclooxygenases in inflammation, cancer, and development
2. Aspirin and neoplasia of digestive tract: Is there a chemopreventive effect?
3. Colon cancer prevention by NSAIDs: What is the mechanism of action?
4. Cyclooxygenase-2 and carcinogenesis
5. Treatment of colonic and rectal adenomas with sublindac in familial adenomatous polyposis
6. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent
7. Sulindac suppresses tumorigenesis in the Min mouse
8. Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines
9. Mechanisms underlying nonsteroidal anti-inflamatory drug-mediated apoptosis
10. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells
11. Role of BAX in the apoptotic response to anticancer agents
12. Apoptosis control by death and decoy receptors
13. Apoptosis signaling by death receptors
14. Death and decoy receptors in p53-mediated apoptosis Leukemia (Baltimore)
15. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis
16. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway
17. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB
18. FADD/MORT1 and caspase-8 we recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
19. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5
20. FADD is required for DR4- and DR5-mediated apoptosis: Lack of TRAIL-induced apoptosis in FADD-deficient mouse embryonic fibroblasts
21. BCL-2 family members and the mitochondria in apoptosis
22. p53-dependent and independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and TNF-α
23. Ultraviolet irradiation-induced apoptosis is mediated via ligand-independent activation of tumor necrosis factor receptor 1
24. KILLER/DR 5 is a DNA damage-inducible p53-regulated death receptor gene
25. The receptor for the cytotoxic ligand TRAIL
26. Functional analysis of TRAIL receptors using monoclonal antibodies
27. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
28. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
29. Identification and molecular cloning of two novel receptors for cytotoxic ligand TRAIL
30. Biochemical pathways of caspase activation during apoptosis
31. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate caner cells by inducing death receptors 4 and 5 protein levels
32. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): Caspase-8 is required for TRAIL-induced apoptosis
33. Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human malignant glioma cells
34. Cytochrome c is involved in Fas-mediated apoptosis of prostatic carcinoma cell lines
35. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
36. Solution structure of BID, an intracellular amplifier of apoptotic signaling
37. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
38. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand